News | Balloon Catheter | May 22, 2017

Abbott Recalls 449,661 Coronary Balloon Catheters

Recall affects three Abbott balloon catheters due to difficulty removing balloon sheath

Abbott recalls its NC Balloon catheters

May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of injury, and one report of death associated with difficulty removing the protective balloon sheath, resulting in issues with inflating or deflating the balloon. Abbott is recalling products from several identified lots because physicians may experience difficulty in removing the protective balloon sheath. This can result in issues with inflating or deflating the balloon during procedures and may cause serious adverse health consequences including air embolism, thrombosis, myocardial infarction and death.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Abbott began contacting customers in March who received coronary catheters from the affected lots and is arranging the return and replacement of all remaining products. The total number of distributed units from identified lots potentially affected is 449,661. Global Health Authorities have been notified of the voluntary recall.

The recalled products include:
• Abbott NC Trek RX Coronary Dilatation Catheter

• Abbott NC Traveler Coronary Dilatation Catheter

• Abbott NC Tenku RX PTCA Balloon Catheter

Specific lots of affected product were manufactured between Jan. 1, 2015 – Jan. 2, 2017, and were distributed between Jan. 13, 2015 – March 14, 2017. Click on the specific catheter links above to see which lots were recalled.

Abbott said the specified balloons may exhibit difficulty in removing the protective balloon sheath, which can result in issues with inflating or deflating the balloon. The worldwide frequency of tight sheath removal, inflation and deflation reported events is 0.12 percent, the company said. In one reported case, failure to deflate the balloon necessitated surgery, leading to multiple post-operative complications and death.

Abbott said this recall does not affect patients having successfully undergone cardiac procedures using these devices. 

On March 22, 2017, Abbott sent a Field Safety Notice letter to healthcare providers and risk managers informing them of the device's risks, and corrective actions that would be implemented to ensure ongoing product performance. The letter asked providers and risk managers to immediately stop using the devices from the identified lots and remove or quarantine them. The vendor also said providers could contact Abbott Vascular to obtain a return authorization number to return all affected and unused products to the company.

Abbott also asked providers to acknowledge receipt of the notification by returning the "Effectiveness Check Form" provided by Abbott Vascular by email to: [email protected], or via fax at (951) 914-5951. 

Abbott's coronary dilatation catheters are indicated for use in balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, coronary artery occlusion in patients with ST-segment elevation myocardial infarction (STEMI), and balloon dilatation of a stent after implantation (2-5 mm balloon models only).

Customers with questions may contact their local Abbott Vascular representative, or contact Abbott's customer service department at (800) 227-9902.

For more information: www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm559603.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Related Content

News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Technology | Balloon Catheter

August 23, 2018 — W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance ...

Home August 23, 2018
Home
Technology | Balloon Catheter

March 21, 2018 — Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) ...

Home March 21, 2018
Home
News | Balloon Catheter

January 24, 2018 — Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product ...

Home January 24, 2018
Home
Videos | Balloon Catheter

A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the ...

Home November 16, 2016
Home
Subscribe Now